Dr. Andi Qipo, MD

Dr. Qipo practices at Englewood Hospital in Englewood, New Jersey, part of RWJBarnabas Health.

Dr. Qipo's NPI, 1164768461, was assigned on December 14, 2012. Dr. Qipo holds New Jersey license 25MA09570500.

Dr. Qipo's primary practice is Englewood Hospital, at 350 Engle St, Englewood, NJ 07631 in Bergen County. The practice phone is (201) 894-3000.

Dr. Qipo's primary practice is Englewood Hospital in Englewood, New Jersey, part of RWJBarnabas Health. The medical group on file is Medical Associates at Englewood. Dmand AI also links Dr. Qipo to 3 more group practices and clinics, 2 home health agencies, 2 medical groups and 1 skilled nursing facility, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Qipo practices, 7 sites in all. Vendor and product names are available with a free account.

Hospitalist is Dr. Qipo's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dmand AI has Dr. Qipo's licenses on file in 2 states: New Jersey and New York.

CMS data shows 385 Medicare services from Dr. Qipo across 4 procedure codes in 2024, for 97 Medicare patients. Medicare paid $23,403 for them. Every service was in an office.

CMS counts 97 Medicare patients who saw Dr. Qipo in 2024. The largest group is 65 to 74, with 48 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 67% are also on Medicaid. Their average risk score is 2.06, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Qipo's median patient age at 67, with 57% women.

In 2024, Dr. Qipo wrote 9,192 Medicare Part D claims for 382 patients. 84% of them were for generic drugs. CMS names the drug for 8,263 of them, across 165 drugs with 11 or more claims each, at $1,079,495 in total drug cost. In 2023, CMS named 7,056 claims across 144 drugs.

Dr. Qipo accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 6 papers to Dr. Qipo, published from 2011 to 2014. 2011 was the busiest year, with 2. The most frequent topics are Diabetes Mellitus, Experimental, Enzyme-Linked Immunosorbent Assay and Graft Rejection. Dr. Qipo has published most often in Am J Transplant. Dr. Qipo's most frequent co-authors are John Cijiang He, MD, Hugh Auchincloss, MD and Hugh G. Auchincloss, MD.

CMS Open Payments shows 79 general payments to Dr. Qipo from 20 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 100% of the total. Novo Nordisk Inc paid the most, $469.